CGEM
Cullinan Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website cullinanoncology.com
- Employees(FY) 62
- ISIN US2300311063
Performance
-8.96%
1W
+60.29%
1M
+50.88%
3M
+181.56%
6M
+162.22%
YTD
+168.81%
1Y
Profile
Cullinan Oncology, Inc. a clinical-stage biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally bioavailable small-molecule that is in a Phase IIb dose escalation for treating patients with non-small cell lung cancer. Its products also include CLN-049, a humanized bispecific antibody that is in Phase I clinical trial for the treatment of acute myeloid leukemia or myelodysplastic syndrome; CLN-619, a monoclonal antibody that is in Phase I clinical trial for the treatment of solid tumors; and CLN-418, a human bispecific antibody that is in Phase 1 clinical trial for the treatment of solid tumors. In addition, the company's preclinical product includes CLN-617, a fusion protein for the treatment of solid tumors; and CLN-978, a T cell engaging antibody for the treatment relapsed/refractory B-cell non-Hodgkin lymphoma. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Investment Analysis Report: CGEM
Overview
CGEM operates in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has shown significant growth in its financial metrics over the past three years, with a notable increase in total assets, revenue, and net income. This report will delve into the valuation, fin...
Technical Analysis of CGEM 2024-05-10
Overview:
In analyzing the technical indicators for CGEM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining key metrics such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights ...
Recent News & Updates
- 2024-05-09 03:09
- 2024-05-01 07:05
- 2024-04-29 07:00
- 2024-04-28 19:00
- 2024-04-24 16:29
- 2024-04-24 10:09
- 2024-04-23 22:09
- 2024-04-16 15:32
- 2024-04-16 07:00
- 2024-04-16 06:59
- 2024-04-16 04:48
Cullinan changes name, pivots to autoimmune disease(BioPharma Dive)
- 2024-04-15 19:00
- 2024-04-15 18:59
- 2024-03-16 05:31
- 2024-03-15 07:34
- 2024-03-14 07:00
- 2024-03-14 00:53
CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023(Investorplace)
- 2024-03-13 19:00
- 2024-03-01 07:00
- 2024-02-27 08:00
- 2024-02-26 19:00
- 2024-02-21 09:21
13 Best Booming Stocks to Buy Right Now(Insider Monkey)
- 2024-02-02 23:01
- 2024-01-30 23:01
- 2024-01-24 19:02
- 2023-12-18 16:53
- 2023-12-18 03:53
- 2023-12-14 16:30
- 2023-12-14 03:30
- 2023-11-08 07:00
Page 1 of 5
previousnext